Validity of criteria used to evaluate fingerstick devices that assess International Normalized Ratio

Medical Decision Making

Volumn 26, Issue 3, 2006, Pages 239-246

  Shermock, Kenneth M ^a   Connor, Jason T ^b,c   Smith, Nicole T ^d   Fink, Jodie M ^b   Bragg, Lee ^e  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e St John West Shore Hospital   (United States)

Author keywords

Bias; International Normalized Ratio; Outcome assessment; Point of care systems; Validity; Warfarin

Indexed keywords

WARFARIN;

ANALYTICAL EQUIPMENT; ANTICOAGULANT THERAPY; ARTICLE; BAYES THEOREM; CRITERION RELATED VALIDITY; DEVICE; DOSE CALCULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; OUTCOME ASSESSMENT; POINT OF CARE TESTING;

ANTICOAGULANTS; BAYES THEOREM; HUMANS; INTERNATIONAL NORMALIZED RATIO; NEEDLES; POINT-OF-CARE SYSTEMS; WARFARIN;

EID: 33646539472     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X06288681     Document Type: Article

References (25)

1. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S-21S.
2. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119:176S-93S.
3. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:194S-206S.
4. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. 2001;119:220S-7S.
5. Hylek EM. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors. Semin Vasc Med. 2003;3:271-8.
6. Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612-7.
7. Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001;135:393-400.
8. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
9. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307-17.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
11. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995;346:1085-7.
12. Bussey HI, Chiquette E, Bianco TM, et al. A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy. 1997;17:861-6.
13. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med. 1995;155:1861-7.
14. Reiss RA, Haas CE, Griffis DL, Porter B, Tara MA. Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapies. Pharmacotherapy. 2002;22(6):677-85.
15. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med. 1992;152:589-92.
16. Hobbs FD, Fitzmaurice DA, Murray ET, Holder R, Rose PE, Roper JL. Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings. J Clin Pathol. 1999;52:494-7.
17. Touchette DR, Popovic B, Racine E, Andersen JC, Massanari MR, Stevenson JG. Correlation and clinical assessment of a portable PT/INR monitor in a cardiology ambulatory clinic. Pharmacotherapy. 2000;20:1236.
18. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med. 1993;153:1441-7.
19. van den Besselaar A. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis. 2002;12:35-40.
20. Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalization ratio monitor in outpatients receiving long-term oral anticoagulation therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res. 1998;92:11-17.
21. Reed C, Rickman H. Accuracy of international normalized ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health Syst Pharm. 1999;56:1619-23.
22. Shermock KM, Bragg LJ, Connor JT, Fink J, Mazzoli G, Kottke-Marchant K. Differences in warfarin dosing decisions based on International Normalized Ratio measurement with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy. 2002;22:1397-404.
23. Murray ET, Fitzmaurice DA, Allan TF, Hobbs FD. A primary care evaluation of three near patient coagulometers. J Clin Pathol. 1999;52:842-5.
24. Carlin BP, Louis TA. Bayes and Empirical Bayes Methods for Data Analysis. New York: Chapman & Hall; 2000.
25. Lunn DJ, Thomas A, Best NG, Spiegel Halter DJ. WinBUGS - a Bayesian modeling framework: concepts, structure and extensibility. Statistics Comput. 2000;10:321-33.